Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program.

Literature DB >> 34542384

Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program.

Paul Gaston Van Buynder¹, Angela Newbound², C Raina MacIntyre³, Alexander Thomas Kennedy⁴, Christopher Clarke⁴, Jonathan Anderson⁴.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 34542384 PMCID： PMC8828056 DOI： 10.1080/21645515.2021.1967042

Source DB: PubMed Journal: Hum Vaccin Immunother ISSN： 2164-5515 Impact factor: 3.452

× No keyword cloud information.

2 in total

1. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.

Authors: Seth Toback; Eva Galiza; Catherine Cosgrove; James Galloway; Anna L Goodman; Pauline A Swift; Sankarasubramanian Rajaram; Alison Graves-Jones; Jonathan Edelman; Fiona Burns; Angela M Minassian; Iksung Cho; Lakshmi Kumar; Joyce S Plested; E Joy Rivers; Andreana Robertson; Filip Dubovsky; Greg Glenn; Paul T Heath
Journal: Lancet Respir Med Date: 2021-11-17 Impact factor: 30.700

2. Seasonal influenza vaccination during a pandemic.

Authors: Heather Richmond; Natasha Rees; Sharon McHale; Aaron Rak; Jonathan Anderson
Journal: Hum Vaccin Immunother Date: 2020-07-31 Impact factor: 3.452

2 in total

5 in total

1. Flu and COVID-19 Vaccination: What Happens to the Flu Shot When the Campaigns Overlap? Experience from a Large Italian Research Hospital.

Authors: Domenico Pascucci; Mario Cesare Nurchis; Alberto Lontano; Eleonora Marziali; Giuseppe Vetrugno; Andrea Cambieri; Umberto Moscato; Andrea Di Pilla; Gianfranco Damiani; Patrizia Laurenti
Journal: Vaccines (Basel) Date: 2022-06-19

Review 5. COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy.

Authors: Alexander Domnich; Andrea Orsi; Carlo-Simone Trombetta; Giulia Guarona; Donatella Panatto; Giancarlo Icardi
Journal: Pharmaceuticals (Basel) Date: 2022-03-08

5 in total

Australian experience of the SH21 flu vaccination program during the COVID-19 vaccine program.

1. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.

2. Seasonal influenza vaccination during a pandemic.

1. Flu and COVID-19 Vaccination: What Happens to the Flu Shot When the Campaigns Overlap? Experience from a Large Italian Research Hospital.

2. Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey.

3. Is the UK prepared for seasonal influenza in 2022-23 and beyond?

4. The Co-Administration of COVID-19 and Hepatitis B Vaccines, Should Safety Be a Concern?

Review 5. COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy.